As part of new agreements announced at the 7th edition of the Global Health Forum, Saudi Arabia signed deals to localize the ...

Diabetes is a global health concern, making it essential to ensure a continuous and reliable supply of high-quality insulin ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has ...

NUPCO signs over 15 new MoUs at the Global Health Exhibition 2024, deepening its ties with the private sector and advancing ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and health care company, has ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of ...

France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

$468 $279 for your first year, equivalent to $23.25 per month. Make up your own mind. Build robust opinions with the FT’s trusted journalism. Take this offer before 24 October.

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

Novo Nordisk May Proceed with Its Ozempic Suit Against DCA Pharmacy. A Tennessee federal court denied DCA Pharmacy’s motion ...